Trials / Completed
CompletedNCT01433510
Tolerability of Grazax in Patients With Hayfever in Real Life Settings
Observational National Clinical Trial of Safety and Tolerance in Patients Suffering of an Allergic Grass Pollen Rhinitis and Treated by Grazax in Real Life Settings
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 628 (actual)
- Sponsor
- ALK-Abelló A/S · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the safety profile of specific immunotherapy with Grazax for three consecutive grass pollen seasons.
Detailed description
To assess the safety profile with Grazax according to the presence or not of polysensitization and/or asthma at enrollment
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Grazax | 1 tablet/day - pre and co-seasonal |
Timeline
- Start date
- 2007-11-01
- Primary completion
- 2010-10-01
- Completion
- 2010-12-01
- First posted
- 2011-09-14
- Last updated
- 2024-05-29
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01433510. Inclusion in this directory is not an endorsement.